blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2508623

EP2508623 - DNA methylation markers and methods of use [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.06.2016
Database last updated on 11.09.2024
Most recent event   Tooltip13.07.2018Lapse of the patent in a contracting state
New state(s): TR		published on 15.08.2018  [2018/33]
Applicant(s)For all designated states
The Johns Hopkins University
3400 N. Charles Street
Baltimore, MD 21218 / US
[2012/41]
Inventor(s)01 / Brock, Malcolm V.
1240 Berans Road
Owings mills, MD 21117 / US
02 / Baylin, Stephen
1241 Riverside Avenue
Baltimore, MD 21230 / US
03 / Herman, James G.
206 Dunbeath Ct.
Lutherville MD 21093 / US
 [2012/41]
Representative(s)Hiebl, Inge Elisabeth
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[2015/33]
Former [2012/41]Hiebl, Inge Elisabeth
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Application number, filing date12163883.720.11.2007
[2012/41]
Priority number, dateUS20060860196P20.11.2006         Original published format: US 860196 P
[2012/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2508623
Date:10.10.2012
Language:EN
[2012/41]
Type: B1 Patent specification 
No.:EP2508623
Date:12.08.2015
Language:EN
[2015/33]
Search report(s)(Supplementary) European search report - dispatched on:EP07.09.2012
ClassificationIPC:C12Q1/68
[2012/41]
CPC:
A61P35/00 (EP); C12Q1/6886 (EP,US); C12Q2600/112 (EP,US);
C12Q2600/118 (EP,US); C12Q2600/154 (EP,US); C12Q2600/16 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/33]
Former [2012/41]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:DNA-Methylierungsmarker und Verwendungsverfahren[2012/41]
English:DNA methylation markers and methods of use[2012/41]
French:Marqueurs de méthylation de l'ADN et leurs méthodes d'utilisation[2012/41]
Examination procedure10.04.2013Amendment by applicant (claims and/or description)
10.04.2013Examination requested  [2013/21]
27.09.2013Despatch of a communication from the examining division (Time limit: M06)
07.04.2014Reply to a communication from the examining division
26.05.2014Despatch of a communication from the examining division (Time limit: M06)
05.12.2014Reply to a communication from the examining division
19.02.2015Communication of intention to grant the patent
16.06.2015Fee for grant paid
16.06.2015Fee for publishing/printing paid
16.06.2015Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07862181.0  / EP2102361
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070862181) is  12.04.2010
Opposition(s)13.05.2016No opposition filed within time limit [2016/29]
Fees paidRenewal fee
12.04.2012Renewal fee patent year 03
12.04.2012Renewal fee patent year 04
12.04.2012Renewal fee patent year 05
26.11.2012Renewal fee patent year 06
27.11.2013Renewal fee patent year 07
26.11.2014Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.11.2007
AT12.08.2015
BG12.08.2015
CY12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
MT12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
TR12.08.2015
GR13.11.2015
IE20.11.2015
LU20.11.2015
CH30.11.2015
LI30.11.2015
IS12.12.2015
PT14.12.2015
[2018/33]
Former [2017/39]HU20.11.2007
AT12.08.2015
BG12.08.2015
CY12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
MT12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
IE20.11.2015
LU20.11.2015
CH30.11.2015
LI30.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/45]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
IE20.11.2015
LU20.11.2015
CH30.11.2015
LI30.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/36]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
LU20.11.2015
CH30.11.2015
LI30.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/34]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SK12.08.2015
GR13.11.2015
LU20.11.2015
CH30.11.2015
LI30.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/31]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SK12.08.2015
GR13.11.2015
LU20.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/28]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/23]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/22]AT12.08.2015
CZ12.08.2015
DK12.08.2015
EE12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/21]AT12.08.2015
DK12.08.2015
ES12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/20]AT12.08.2015
DK12.08.2015
ES12.08.2015
FI12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/14]AT12.08.2015
ES12.08.2015
FI12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/11]AT12.08.2015
ES12.08.2015
FI12.08.2015
LT12.08.2015
LV12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/10]ES12.08.2015
FI12.08.2015
LT12.08.2015
LV12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/09]FI12.08.2015
LT12.08.2015
LV12.08.2015
GR13.11.2015
Former [2016/07]LT12.08.2015
Documents cited:Search[A]WO2005042713  (UNIV JOHNS HOPKINS [US], et al) [A] 1-16 * the whole document *;
 [A]WO0244331  (CANGEN INTERNAT [US]) [A] 1-16 * the whole document *
 [Y]  - LIU Y ET AL, "Hypermethylation of p16INK4a in chinese lung cancer patients : biological and clinical implications", CARCINOGENESIS, XX, XX, (20030101), vol. 24, no. 12, pages 1897 - 1901, XP002305903 [Y] 1-16 * the whole document *
 [X]  - NAKATA SHOJI ET AL, "The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma - Epigenetic silencing, clinical features, and prognostic significance", CANCER, (200605), vol. 106, no. 10, ISSN 0008-543X, pages 2190 - 2199, XP008155286 [X] 6-16 * the whole document *

DOI:   http://dx.doi.org/10.1002/cncr.21870
 [X]  - HARDEN SUSAN V ET AL, "Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH APR 2003 LNKD- PUBMED:12684406, (200304), vol. 9, no. 4, ISSN 1078-0432, pages 1370 - 1375, XP002682306 [X] 1-5 * the whole document *
 [Y]  - ZOCHBAUER-MULLER S ET AL, "Aberrant promoter methylation of multiple genes in non-small cell lung cancers", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20010101), vol. 61, no. 1, ISSN 0008-5472, pages 249 - 255, XP002251520 [Y] 1-16 * the whole document *
 [Y]  - ESTELLER M ET AL, "Detection of aberrant promotor hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (19990101), vol. 59, ISSN 0008-5472, pages 67 - 70, XP002959643 [Y] 1-16 * the whole document *
ExaminationWO0218649
    - HOJOONG KIM ET AL, "Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer", JOURNAL OF CLINICAL ONCOLOGY, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US, (20040615), vol. 22, no. 12, doi:10.1200/JCO.2004.10.077, ISSN 0732-183X, pages 2363 - 2370, XP002641112

DOI:   http://dx.doi.org/10.1200/JCO.2004.10.077
    - ZÖCHBAUER-MÜLLER SABINE ET AL, "Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER 20 NOV 2003, (20031120), vol. 107, no. 4, ISSN 0020-7136, pages 612 - 616
    - KIM Y T ET AL, "Can Aberrant Promoter Hypermethylation of CpG Islands Predict the Clinical Outcome of Non-Small Cell Lung Cancer After Curative Resection?", THE ANNALS OF THORACIC SURGERY, ELSEVIER, UNITED STATES, vol. 79, no. 4, ISSN 0003-4975, (20050401), pages 1180 - 1188, (20050401), XP027732305
    - JIN S K ET AL, "Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20060415), Database accession no. EMB-2006208416
    - JIN S K ET AL, "Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer", CANCER RESEARCH 20060415 US, (20060415), vol. 66, no. 8, ISSN 0008-5472, pages 4049 - 4054
by applicantUS2005239101
 US7214485
 US6017704
 US5786146
 US6200756
 US6265171
 US4458066
 US7144701
 US4683195
 US4683202
 US4800159
    - BAYLIN ET AL., ADV. CANCER RES., (1998), vol. 72, pages 141 - 196
    - RINSHO, BYORI, Genpatsusei Kangan Toriatsukaikiyaku, NIHON KANGANGAKU KENKYUKAI, (1992), page 22
    - BIRD, A., NATURE, (1986), vol. 321, page 209
    - LI ET AL., NATURE, (1993), vol. 366, page 362
    - SAKAI ET AL., AM. J. HUM. GENET., (1991), vol. 48, page 880
    - HERMAN ET AL., PROC. NATL. ACAD. SCI., U.S.A., (1994), vol. 91, page 9700
    - ISSA ET AL., NATURE GENET., (1994), vol. 7, page 536
    - MERLO ET AL., NATURE MED., (1995), vol. 1, page 686
    - HERMAN ET AL., CANCER RES., (1996), vol. 56, page 722
    - GRAFF ET AL., CANCER RES., (1995), vol. 55, page 5195
    - HERMAN ET AL., CANCER RES., (1995), vol. 55, page 4525
    - FROMMER ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, page 1827
    - CLARK ET AL., NUCLEIC ACIDS RESEARCH, (1994), vol. 22, page 2990
    - BEAUCAGE ET AL., TETRAHEDRON LETTERS, (1981), vol. 22, pages L859 - 1862
    - KUHN HOFFINANN-BERLING, CSH-QUANTITATIVE BIOLOGY, (1978), vol. 43, page 63
    - C. RADDING, ANN. REV. GENETICS, (1982), vol. 16, pages 405 - 437
    - MANIATIS ET AL., Molecular Cloning: A Laboratory Manual, COLD SPRING HARBOR, N.Y., (1982), page 280,281
    - SAIKI ET AL., SCIENCE, (1988), vol. 239, pages 487 - 491
    - HELLMAN S., "Stopping metastases at their source", N ENGL J MED, (1997), vol. 337, pages 996 - 7
    - RIETHMULLER G; JOHNSON JP, "Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers", CURR OPIN IMMUNOL, (1992), vol. 4, pages 647 - 55
    - ZHU JJ; MARUYAMA T; JACOBY LB ET AL., "Clonal analysis of a case of multiple meningiomas using multiple molecular genetic approaches: pathology case report", NEUROSURGERY, (1999), vol. 45, pages 409 - 16
    - MARTINI N; BAINS MS; BURT ME ET AL., "Incidence of local recurrence and second primary tumors in resected stage I lung cancer", J THORAC CARDIOVASC SURG, (1995), vol. 109, doi:doi:10.1016/S0022-5223(95)70427-2, pages 120 - 9, XP005143890

DOI:   http://dx.doi.org/10.1016/S0022-5223(95)70427-2
    - MOUNTAIN CF., "Revisions in the International System for Staging Lung Cancer", CHEST, (1997), vol. 111, pages 1710 - 7
    - HOFFINAN PC; MAUER AM; VOKES EE, "Lung cancer", LANCET, (2000), vol. 355, pages 479 - 85
    - HERMAN JG; BAYLIN SB, "Gene silencing in cancer in association with promoter hypermethylation", N ENGL J MED, (2003), vol. 349, doi:doi:10.1056/NEJMra023075, pages 2042 - 54, XP008114714

DOI:   http://dx.doi.org/10.1056/NEJMra023075
    - BAYLIN SB; OHM JE, "Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?", NAT REV CANCER, (2006), vol. 6, pages 107 - 16
    - HERMAN JG; GRAFF JR; MYOHANEN S; NELKIN BD; BAYLIN SB, "Methylation-specific PCR: a novel PCR assay for methylation status ofCpG islands", PROC NATL ACAD SCI U S A, (1996), vol. 93, pages 9821 - 6, XP055092786
    - ESTELLER M; CORN PG; BAYLIN SB; HERMAN JG, "A gene hypermethylation profile of human cancer", CANCER RES, (2001), vol. 61, pages 3225 - 9
    - PELLISE M; CASTELLS A; GINES A ET AL., "Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography- guided fine-needle aspiration biopsy", CLIN CANCER RES, (2004), vol. 10, pages 4444 - 9
    - SANCHEZ-CESPEDES M; ESTELLER M; HIBI K ET AL., "Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence", CLIN CANCER RES, (1999), vol. 5, pages 2450 - 4, XP002977985
    - KOLLERMANN J; MULLER M; GOESSL C ET AL., "Methylation-specific PCR for DNA- based detection of occult tumor cells in lymph nodes of prostate cancer patients", EUR UROL, (2003), vol. 44, pages 533 - 8
    - HARDEN SV; TOKUMARU Y; WESTRA WH ET AL., "Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients", CLIN CANCER. RES, (2003), vol. 9, pages 1370 - 5
    - BELINSKY SA; NIKULA KJ; PALMISANO WA ET AL., "Aberrant methylation of p16(INIC4a) is an early event in lung cancer and a potential biomarker for early diagnosis", PROC NATL ACAD SCI U S A, (1998), vol. 95, doi:doi:10.1073/pnas.95.20.11891, pages 11891 - 6, XP002906659

DOI:   http://dx.doi.org/10.1073/pnas.95.20.11891
    - TOYOOKA KO; TOYOOKA S; VIRMANI AK ET AL., "Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas", CANCER RES, (2001), vol. 61, pages 4556 - 60, XP055107860
    - TOYOOKA S; TOYOOKA KO; MARUYAMA R ET AL., "DNA methylation profiles of lung tumors", MOL CANCER THER, (2001), vol. 1, pages 61 - 7, XP002251519
    - MACHIDA EO; BROCK MV; HOOKER CM ET AL., "Hypermethylation of ASC/TMS 1 is a sputum marker for late-stage lung cancer", CANCER RES, (2006), vol. 66, doi:doi:10.1158/0008-5472.CAN-05-4447, pages 6210 - 8, XP002502183

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-05-4447
    - BROCK MV; KIM MP; HOOKER CM ET AL., "Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience", ANN THORAC SURG, (2004), vol. 77, pages 271 - 7
    - ETTINGER DS; COX JD; GINSBERG RJ ET AL., "NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network", ONCOLOGY (WILLISTON PARK, (1996), vol. 10, pages 81 - 111
    - JOHNSON BE, "NCCN: Small cell lung cancer", CANCER CONTROL, (2001), vol. 8, pages 32 - 43
    - GINSBERG RJ; RUBINSTEIN LV, "Randomized trial of lobectomy versus limited resection for T1 NO non-small cell lung cancer. Lung Cancer Study Group", ANN THORAC SURG, (1995), vol. 60, pages 615 - 22,622-3
    - HOUSE MG; GUO M; EFRON DT ET AL., "Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior", J GASTROINTEST SURG, (2003), vol. 7, pages 1004 - 14
    - VAN ENGELAND M; WEIJENBERG MP; ROEMEN GM ET AL., "Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer", CANCER RES, (2003), vol. 63, pages 3133 - 7
    - GUO M; REN J; HOUSE MG; QI Y; BROCK MV; HERMAN JG, "Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus", CLIN CANCER RES, (2006), vol. 12, pages 4515 - 22
    - VAN ENGELAND M; ROEMEN GM; BRINK M ET AL., "K-ras mutations and RASSFIA promoter methylation in colorectal cancer", ONCOGENE, (2002), vol. 21, doi:doi:10.1038/SJ/ONC/1205466, pages 3792 - 5, XP008102911

DOI:   http://dx.doi.org/10.1038/SJ/ONC/1205466
    - ESTELLER M; GARCIA-FONCILLAS J; ANDION E ET AL., "Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents", N ENGL J MED, (2000), vol. 343, pages 1350 - 4
    - BROCK MV; GOU M; AKIYAMA Y ET AL., "Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma", CLIN CANCER RES, (2003), vol. 9, pages 2912 - 9
    - TANG X; KHURI FR; LEE JJ ET AL., "Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer", J NATL CANCER INST, (2000), vol. 92, doi:doi:10.1093/jnci/92.18.1511, pages 1511 - 6, XP002959642

DOI:   http://dx.doi.org/10.1093/jnci/92.18.1511
    - POTTI A; MUKHERJEE S; PETERSEN R ET AL., "A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer", N ENGL J MED, (2006), vol. 355, doi:doi:10.1056/NEJMoa060467, pages 570 - 80, XP009096340

DOI:   http://dx.doi.org/10.1056/NEJMoa060467
    - BRUNDAGE MD; DAVIES D; MACKILLOP WJ, "Prognostic factors in non-small cell lung cancer: a decade of progress", CHEST, (2002), vol. 122, pages 1037 - 57
    - CHEN HY; YU SL; CHEN CH ET AL., "A five-gene signature and clinical outcome in non-small-cell lung cancer", N ENGL J MED, (2007), vol. 356, doi:doi:10.1056/NEJMoa060096, pages 11 - 20, XP009086044

DOI:   http://dx.doi.org/10.1056/NEJMoa060096
    - GU J; BERMAN D; LU C ET AL., "Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer", CLIN CANCER RES, (2006), vol. 12, pages 7329 - 38
    - BELINSKY SA; LIECHTY KC; GENTRY FD, "Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort", CANCER RES, (2006), vol. 66, pages 3338 - 44
    - GORE SD; BAYLIN S; SUGAR E ET AL., "Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms", CANCER RES, (2006), vol. 66, doi:doi:10.1158/0008-5472.CAN-06-0080, pages 6361 - 9, XP002477180

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-06-0080
    - FEARON, CELL, (1990), vol. 61, page 759
    - JONES ET AL., CANCER RES., (1986), vol. 46, page 461
    - BAYLIN ET AL., CANCER CELLS, (1991), vol. 3, page 383
    - SAIKI ET AL., BIO/TECHNOLOGY, (1985), vol. 3, pages 1008 - 1012
    - CONNER ET AL., PROC. NATL. ACAD. SCI. USA, (1983), vol. 80, page 278
    - LANDEGREN ET AL., SCIENCE, (1988), vol. 241, page 1077
    - LANDEGREN ET AL., SCIENCE, (1988), vol. 242, pages 229 - 237
    - MANSOUR ET AL., N. ENGL. J. MED., (1989), vol. 320, pages 485 - 490
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.